Background
South African cassava mosaic virus is one of many cassava mosaic geminivirus species that affect the important food crop, cassava (
Manihot esculenta Crantz), causing the distinct foliar symptoms characterised as cassava mosaic disease (CMD). CMD symptoms include mosaic pattern leaf chlorosis, curling, shape distortion and reduced size; which lead to production of few or no tubers [
3,
66].
South African cassava mosaic virus (SACMV) occurrence was first reported in South Africa and Swaziland [
11], then subsequently in Zimbabwe [
15] and Madagascar [
24]. This bipartite begomovirus with a single-stranded DNA genome was identified as a distinct geminivirus based on DNA A sequence comparison, serology, and amplification of a DNA B fragment; and it was shown to have high sequence similarity with tomato yellow leaf curl virus (TYLCV), a monopartite begomovirus [
12,
13]. SACMV is transmitted by the whitefly species complex (
Bemisia tabaci Genn.) [
37] and perpetuated through infected stem cuttings used for propagation [
21]. The effect of SACMV on cassava yield is dependent on the cassava genotype and environmental conditions, and it varies from no effect to total crop loss [
66]. Major regional pandemics of CMD can cause major food security destabilisation, such as that which occurred in East and Central Africa in the 1990s [
46,
47].
Established strategies for reducing incidence of CMD, such as use of virus-free cuttings and conventional breeding for genetic improvement of cassava using resistant landraces [
17,
36,
46,
69,
71], have not been effective in reducing cassava yield loss. Genetic modification of cassava for introduction of resistance traits has been hampered by this non-model plant’s recalcitrance to transformation [
49,
99]. Furthermore, these approaches are time-consuming, causing attention to shift to the use of newer biotechnological approaches such as CRISPR-mediated gene editing [
77].
Certain cassava genotypes exhibit natural resistance or tolerance to cassava mosaic begomoviruses (CMBs), for example, tropical
M. esculenta 3 (TME3) [
2] and Tropical Manihot Series (TMS) 96/0023 [
30]), whereas others (cv.60444, T200, TMS 8017) are susceptible to CMBs and do not recover from infection (reviewed in [
28,
48]. Although it is not clear which particular genes are involved in cassava’s response to SACMV infection, the availability of naturally-resistant cassava genotypes, transcriptomic data from infected susceptible and tolerant cassava genotypes [
5], genome-wide association study data [
94] and the cassava genome [
14,
41,
75] enables the selection of putative host interacting genes for screening and testing.
Existing methods of cassava transformation are laborious, taking at least fifteen weeks from commencement of plant cultures to gene expression assaying [
49,
99]. Transforming plant protoplasts instead of whole plants has a relatively shorter turnaround time, and is desirable because protoplasts show comparable cell-independent responses as whole plants [
85,
98]. Transient transformation of plant protoplasts for rapid gene characterisation is well-established for several plant species [
1,
38,
56,
68,
76,
96]. More recently, cassava protoplasts were used for rapid gene characterisation [
96] because they are a demonstrably reliable system for correlating
in planta activities. Further, co-transformation of plant protoplasts with multiple plasmid constructs is routinely conducted [
18,
55,
91] and specifically plant protoplast co-transformation with virus infectious clones and plasmid constructs has been used to explore gene function during viral infection [
20,
89].
We propose that simultaneous targeted mutagenesis and viral infection can facilitate characterisation of the genetic architecture during the diseased state, and if coupled in protoplasts, can provide a high-throughput rapid screening platform for genes that may be central to
in planta host-virus interactions. Potential gene candidates can then be further validated
in planta using virus-induced gene silencing (VIGS). To explore this, we targeted a cassava ubiquitin E3 ligase gene,
MeE3L (
Manes.12g069400), for CRISPR-mediated mutagenesis in SACMV-infected cassava protoplasts from the model cultivar (60,444), and susceptible (T200) and tolerant (TME3) African cassava landraces.
MeE3L was targeted because ubiquitin RING E3 ligases play a central role in the hijacking and redirection of ubiquitination by geminiviruses [
4,
31,
58,
90]. Moreover,
MeE3L has previously been implicated in the response to stress [
50,
73] and associated with the CMD2 resistance locus [
57,
94]. We analysed primary
MeE3L gene structure, predicted MeE3L protein tertiary structure,
MeE3L expression and SACMV DNA accumulation to determine whether
MeE3L may be involved in the response of cassava protoplasts to SACMV infection. Findings in this study demonstrated the suitability of the cassava protoplast system for high-throughput screening of the genes involved in cassava’s response to SACMV.
Conclusions
We have developed a simple and faster protocol for CRISPR-mediated transient gene expression assaying in cassava protoplasts infected with SACMV. While existing gene editing protocols for cassava plants take about 15 weeks, our protoplast-based method takes 7 weeks to provide experimental data that is suitable for screening candidate genes and informing in planta functional genomics studies. Using this protocol, we show that SACMV DNA accumulation in cassava protoplasts is genotype-dependent and it induces silencing of the MeE3L RING domain in susceptible T200 and tolerant TME3 landraces. We provide evidence for differential expression of native and mutant MeE3L during SACMV infection of cassava protoplasts. We also reveal that a SACMV-susceptible southern African cassava landrace (T200) expresses a mutant MeE3L with a silenced RING domain.
While this protocol cannot account for events relating to cell-to-cell signalling and movement, it does provide a basis for tentative identification of genes that respond to geminiviral infection in cassava. It may be adapted for high-throughput screening by targeting several genes simultaneously using a CRISPR multiplex approach.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.